Enterprise Value
1.203B
Cash
481.1M
Avg Qtr Burn
-40.99M
Short % of Float
0.59%
Insider Ownership
5.71%
Institutional Own.
85.17%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Obicetrapib + ezetimibe Details Dyslipidemia, Hypercholesterolemia | Phase 3 Data readout | |
Obicetrapib Details Heterozygous familial hypercholesterolemia, Atherosclerotic cardiovascular disease Big Mover™ Suspected Mover™ Susp. Mover™ | Phase 3 Data readout | |
Obicetrapib Details Alzheimer's disease | Phase 2a Data readout |